Contemplated compositions and methods sensitize tumor cells to a cancer treatment regimen, including chemotherapy, radiation therapy, and immune therapy by preventing EMT (epidermal to mesenchymal transition) of the tumor cell, or by reversing the tumor cell from a mesenchymal to an epidermal state. Thusly sensitized cells are then subjected to the cancer treatment regimen.
